Lívia N. F. Guerreiro‐Costa

Intravenous arketamine for treatment-resistant depression: open-label pilot study

Gustavo C. Leal, Igor D. Bandeira, Fernanda S. Correia‐Melo et al. · European Archives of Psychiatry and Clinical Neuroscience · 2020 · 257 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study

Gustavo C. Leal, Breno Souza‐Marques, Rodrigo P. Mello et al. · Journal of Affective Disorders · 2023 · 59 citations

Medicine, Pharmacology, Psychiatry +15

Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression

Ana Paula Jesus‐Nunes, Gustavo C. Leal, Fernanda S. Correia‐Melo et al. · Human Psychopharmacology Clinical and Experimental · 2022 · 39 citations

Medicine, Pharmacology, Psychiatry +17

Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study

Lucas Araújo-de-Freitas, Cassio Santos‐Lima, Euclides Mendonça-Filho et al. · Psychiatry Research · 2021 · 38 citations

Medicine, Pharmacology, Psychiatry +16

Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial

Rodrigo P. Mello, Mariana V.F. Echegaray, Ana Paula Jesus‐Nunes et al. · Journal of Psychiatric Research · 2021 · 22 citations

Pharmacy, Psychiatry, Psychology +17